Injectable triamcinolone formulations
US12419833B2 · kind B2 · utility
0Cited by
2References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2020 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Apr 16, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical suspensions of triamcinolone acetonide, methods of producing such suspensions and methods of using of such suspensions. The pharmaceutical suspensions of the present disclosure are stable and suitable for administration by suprachoroidal injection through a 30-gauge microneedle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.